BoogarLists
Directory
Alpha
Angels
Services
US Listing
Clean Tech
Asian Pacific
Europe Listing
Mid-Market/LBO
Bio-Life Sciences
Real Estate Fund
Australia Listing
Canada Listing
Israel Listing
Universities
Networks
Social
 


Bio-Life Sciences

 

 

< 123 A B C D E F G H I J-K L M N O P Q-R S T-U V W-Z >

 

-De Novo-

De Novo Ventures
Offices: Menlo Park, California
De Novo Ventures has strived to build a healthcare investment firm that is differentiated by its approach, valued for its knowledge, and distinguished by its performance. The Principals have an average of 18 years experience in the targeted sectors, have founded or co-founded 8 companies that sold for over $1.6 billion, and have invested in 35 companies as managers of venture capital firms prior to the formation of De Novo.
Devon Park Bioventures
Offices: Wayne, Pennsylvania
Devon Park Bioventures is within driving distance of the headquarters of many of the world’s largest pharmaceutical companies, major medical research universities, the premier financial institutions of Wall Street, federal research and regulatory agencies and hundreds of biotechnology companies. Devon Park's proximity to this critical mass of biotechnology and pharmaceutical activity makes it well positioned to take advantage of new opportunities.
Domain Associates
Offices: Laguna Niguel, California & Princeton, New Jersey
Founded in 1985, Domain Associates is a venture capital firm with an exclusive focus on life sciences. With $1.4 billion of capital under management, Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. Their partners have a total of close to 200 person-years of experience among them.
Draper Fisher Jurvetson Incube (DFJ InCube Ventures)
Offices: San Jose, California
DFJ InCube Ventures is a venture capital firm focused on innovative medical technologies that can significantly improve clinical outcomes. ICV is led by Mir Imran, one of the world's most successful medical device innovators. Mir is joined by Andrew Farquharson and Wayne Roe, proven entrepreneurs and investors in their own right. All three managing directors have built world-dominant companies in therapeutics, reimbursement and research.
DRI Capital
Offices: Toronto, Ontario
DRI Capital manages a fund that acquires royalties from pharmaceutical and biotechnology companies in addition to research institutes, universities and inventors. Acquisition criteria are not limited to any specific therapeutic category and there is a preference for products that have been approved by the FDA and/or the EMEA. Because the investments are long-term in nature the strength of the underlying intellectual property is critical.
DSM Venturing
Offices: The Netherlands
DSM Venturing is an active investor in start-up companies and Venture Capital Funds in the fields of Nutrition, Pharma and Performance Materials. DSM Venturing's mission is to explore emerging markets and technologies in order to enhance DSM's product portfolio and create value. Besides financial support, DSM Venturing supports the start-up companies with DSM's knowledge, resources and networks in order to establish mutual benefits and learnings.
DW Healthcare Partners
Offices: Salt Lake, Utah
Formed in 2002, DW Healthcare Partners is a private equity firm with over $250 million under management. They invest in healthcare companies at the smaller end of the middle market, generating over $3 million in EBITDA. They understand the operational and strategic issues confronting business owners and can help accelerate the growth of businesses and build shareholder value.